Chandra Bhagat Pharma Limited (BOM:542934)
India · Delayed Price · Currency is INR 49.90
-2.60 (-4.95%)
At close: Aug 14, 2026
Chandra Bhagat Pharma Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Operating Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 30.46 | 8.58 | 15.3 | 9.05 | 7.97 |
Depreciation & Amortization | 10.3 | 8.82 | 4.87 | 1.11 | 0.38 |
Other Operating Activities | 26.25 | 15.54 | 16.56 | 21.06 | 31.82 |
Change in Accounts Receivable | -186.72 | 35.02 | -312.61 | 68.18 | 4.14 |
Change in Inventory | -39.8 | 79.85 | 204.01 | 50.79 | 9.83 |
Change in Accounts Payable | 229.33 | -42.79 | 101.29 | 4.31 | -101.82 |
Change in Other Net Operating Assets | 22.55 | -162.11 | 32.33 | -101.86 | 171.67 |
Operating Cash Flow | 92.36 | -57.09 | 61.76 | 52.64 | 123.98 |
Operating Cash Flow Growth | - | - | 17.31% | -57.54% | 48.86% |
Investing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Capital Expenditures | -9.21 | -12.03 | -22.82 | -3.69 | -1 |
Sale of Property, Plant & Equipment | - | 4.5 | - | 0.03 | 0.12 |
Other Investing Activities | 4.86 | -0.3 | 4.29 | 3.07 | 1.74 |
Investing Cash Flow | -4.35 | -7.82 | -18.53 | -0.59 | 0.85 |
Financing Activities
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Short-Term Debt Issued | - | 35.63 | - | - | - |
Long-Term Debt Issued | 2.85 | 5.77 | - | - | - |
Total Debt Issued | 2.85 | 41.4 | - | - | - |
Short-Term Debt Repaid | -46.37 | - | -0.04 | -6.8 | -12.49 |
Long-Term Debt Repaid | - | - | -44.07 | -15.8 | -52.99 |
Total Debt Repaid | -46.37 | - | -44.11 | -22.6 | -65.47 |
Net Debt Issued (Repaid) | -43.53 | 41.4 | -44.11 | -22.6 | -65.47 |
Other Financing Activities | -20.03 | -19.48 | -13.87 | -21.87 | -30.76 |
Financing Cash Flow | -63.56 | 21.92 | -57.98 | -44.47 | -96.24 |
Net Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Miscellaneous Cash Flow Adjustments | 0 | 0 | - | -0 | -0 |
Net Cash Flow | 24.46 | -42.99 | -14.75 | 7.58 | 28.6 |
Free Cash Flow
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 83.15 | -69.11 | 38.94 | 48.96 | 122.99 |
Free Cash Flow Growth | - | - | -20.46% | -60.19% | 48.03% |
Free Cash Flow Margin | 7.12% | -7.61% | 1.75% | 4.09% | 13.07% |
Free Cash Flow Per Share | 11.02 | -9.16 | 5.16 | 6.49 | 16.30 |
Levered Free Cash Flow | 60.82 | -64.54 | 22.16 | 35.34 | 107.38 |
Unlevered Free Cash Flow | 72.56 | -53.31 | 30.21 | 48.93 | 126.03 |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash Interest Paid | 18.78 | 17.96 | 12.87 | 21.64 | 28.39 |
Cash Income Tax Paid | 4.01 | 5.58 | 4.56 | 2.32 | 1.06 |
Change in Working Capital | 25.36 | -90.03 | 25.02 | 21.42 | 83.82 |